Advanced Search

 

Study ID Status Title Patient Level Data
PMK103351 Completed A 28-day, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, anti-inflammatory effect and steady-state pharmacokinetics of SB-681323 (7.5 mg) in subjects with coronary heart disease (CHD) undergoing elective percutaneous coronary interventions (PCI)
RA1100849 Completed A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-reactive protein (CRP) in subjects with rheumatoid arthritis (RA)
RA1101607 Completed A placebo controlled study to evaluate the safety and tolerability of repeat doses of SB-681323 in patients receiving methotrexate for rheumatoid arthritis.
RA1104046 Completed A randomised, placebo-controlled, parallel group single dose study of SB681323 in patients with active RA to investigate the CRP dose response relationship
RA1107570 Completed A study to assess the safety and tolerability of SB-681323 administered via the intravenous route
RA3103718 Completed A randomized, double blind, placebo controlled study to investigate the safety and tolerability and clinical activity of 28 days of oral repeat dosing with GW856553 at 7.5mg BID in subjects with active rheumatoid arthritis on stable anti-rheumatic therapy.
RA3103730 Completed A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the C-Reactive Protein (CRP) dose response relationship
RA4102651 Completed An enabling study to investigate the correlation of biomarkers of the activity of inducible nitric oxide synthase (iNOS) with disease activity and treatment response in patients with rheumatoid arthritis(RA)
RA4104917 Completed A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing of GW274150 or 7.5mg prednisolone in RA subjects. Study Listed on ClinicalStudyDataRequest.com
RES100767 Terminated A Study To Validate Key Therapeutic Targets and Characterise Their Response to Corticosteroids in Multiple Asthma Phenotypes
RES100769 Terminated A study to assess disease pathology and key therapeutic targets in severe asthma
RES101509 Completed An investigation to evaluate the technique of MRI as an assessment of the effect of anti-allergy drug treatment on internal nasal and sinus mucosal anatomy following intranasal allergen challenge in subjects with seasonal allergic rhinitis.
RES104031 Completed A Randomised (with Respect to Microplaque Treatment Positions), Single-Blind, Placebo-Controlled, Positive-Controlled, Microplaque Study to Assess the Effectiveness of a Topical Formulation of GW786034 in Patients with Chronic Plaque Psoriasis
RES106087 Completed A randomized, double-blind study of treatment with a known anti-inflammatory (prednisolone) to evaluate novel endpoints in patients with chronic obstructive pulmonary disease (COPD)
RES11086 Completed Investigation of the side effects of orally administered glucocorticoids. An open label study to investigate the effects of orally administered prednisolone on bone metabolism in patients with COPD.
RH01299 Completed The Effect of Fluoride in an Experimental Dentifrice on Remineralization of Erosive Lesions In-Situ
RH01324 Completed A clinical study investigating the efficacy of a dentifrice in providing short term relief from dentinal hypersensitivity
RH01325 Completed A clinical study investigating the efficacy of a dentifrice in providing long term relief from dentinal hypersensitivity
RH01333 Completed A Randomized, Cross-Over, Single Dose Pharmacokinetic Study of 4mg Nicotine Lozenges.
RH01361 Completed Effects of two doses of a common cold treatment on cognitive function
RH01379 Completed A Single Centre, Examiner-blind Human Patch Test of Bactroban Disinfectant Liquid on Normal Skin
RH01381 Completed In Situ Study to Confirm the Anti-caries Potential of a 1.1365% w/w Sodium Monofluorophosphate (1500ppm F) Dentifrice
RH01390 Completed A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model
RH01418 Completed A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
RH01426 Completed A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.